The interaction of the T cell receptor (TCR) with its specific ligand, the peptide-MHC complex, is only one of the events required for the activation of antigen-specific T cells. The primary goals of our studies are to characterize cell surface antigens (co-receptors) and their soluble or cell associated ligands (counter-receptors) which play critical roles in cell-cell interaction and in the interaction of T cells with their environment. Our studies have focused on two distinct areas: 1) Although the interaction of the B7 family of costimulatory molecules with CD28 on T cells has been shown to play a critical role in providing T cell costimulation for induction of maximal T cell activation, accumulating evidence has suggested the existence of non-B7 mediated costimulation. We have characterized this alternative pathway of costimulation and demonstrated that B cells which have been activated via the CD40 antigen on their cell surface express potent B7/CD28 independent costimulatory activity which was capable of augmenting the activation of CD4+ T cells from CD28 deficient mice. To further characterize the molecules which mediate this alternative costimulatory pathway, we have developed monoclonal antibodies (mAbs) which are capable of blocking its delivery and shown that the TSA-1/sca2 antigen, a member of the Ly-6 gene family, on the activated B cells plays a key role in the delivery of the alternative costimulatory signal. 2) Integrins represent a candidate group of cell surface receptors which may control the homing and population of the thymus by T cell precursors and the subsequent migration of developing thymocytes through the thymic architecture. We have shown that blockade of the interaction of the integrin, alpha4beta1, with its ligands fibronectin (FN) and VCAM-1 inhibits the development of the earliest thymic precursor into immature CD4+ CD8+ (DP) thymocytes. Furthermore, analyses of the expression of VCAM-1 in the thymus revealed its selective localization on cortical thymic epithelial cells, while fibronectin was localized primarily in the thymic medulla. Thus, the selective localization of VCAM-1 to the cortex and FN to the medulla may play an important role in regulating the participation of each ligand in thymocyte development. Lastly, the possible role of integrins in the process of positive selection in the thymus was suggested by the demonstration that engagement of alpha4beta1 on DP thymocytes significantly potentiated anti-CD3 mediated reversal of glucocorticoid induced thymocyte apoptosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000224-15
Application #
2566721
Study Section
Special Emphasis Panel (LI)
Project Start
Project End
Budget Start
Budget End
Support Year
15
Fiscal Year
1996
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Zhu, Jinfang; Davidson, Todd S; Wei, Gang et al. (2009) Down-regulation of Gfi-1 expression by TGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells. J Exp Med 206:329-41
Huter, Eva N; Stummvoll, Georg H; DiPaolo, Richard J et al. (2009) Pre-differentiated Th1 and Th17 effector T cells in autoimmune gastritis: Ag-specific regulatory T cells are more potent suppressors than polyclonal regulatory T cells. Int Immunopharmacol 9:540-5
Huter, Eva N; Punkosdy, George A; Glass, Deborah D et al. (2008) TGF-beta-induced Foxp3+ regulatory T cells rescue scurfy mice. Eur J Immunol 38:1814-21
Shevach, Ethan M; Tran, Dat Q; Davidson, Todd S et al. (2008) The critical contribution of TGF-beta to the induction of Foxp3 expression and regulatory T cell function. Eur J Immunol 38:915-7
Stummvoll, Georg H; DiPaolo, Richard J; Huter, Eva N et al. (2008) Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J Immunol 181:1908-16
Shevach, Ethan M (2006) From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25:195-201
Mendel, Itzhak; Shevach, Ethan M (2006) Activated T cells express the OX40 ligand: requirements for induction and costimulatory function. Immunology 117:196-204
Kullberg, Marika C; Hay, Valerie; Cheever, Allen W et al. (2005) TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol 35:2886-95
Wang, Helen Y; Peng, Guangyong; Guo, Zhong et al. (2005) Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells. J Immunol 174:2661-70
Brinster, Carine; Shevach, Ethan M (2005) Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function. J Immunol 175:7332-40

Showing the most recent 10 out of 48 publications